Aimei Health Technology Co Ltd
Aimei Health Technology Co Ltd is an investment holding company that operates primarily in the financial sector, managing a portfolio of investments and generating income through equity stakes and asset management.
Business. Aimei Health Technology Co Ltd (AFJK.O) is an investment holding company listed on the NASDAQ. The firm operates within the Financials sector, specifically classified under Investment Holding Companies. Detailed information regarding its operating segments, headquarters location, and geographic revenue mix is not available. Consequently, the company is described at the industry level as an entity engaged in investment holding activities.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Aimei Health Technology Co Ltd (AFJK.O) is an investment holding company listed on the NASDAQ. The firm operates within the Financials sector, specifically classified under Investment Holding Companies. Detailed information regarding its operating segments, headquarters location, and geographic revenue mix is not available. Consequently, the company is described at the industry level as an entity engaged in investment holding activities.
Aimei Health Technology Co Ltd maintains a strong liquidity position, as evidenced by a current ratio of 6.13, indicating that the company has significantly more current assets than current liabilities. The company's total equity of $70.5 million is supported by total assets of $71.3 million, with no long-term debt, suggesting a conservative capital structure. The price-to-book ratio of 1.81 and price-to-tangible-book ratio of 1.81 indicate that the company's market value is slightly above its book value, which is in line with the industry norms for investment holding companies.
In terms of profitability, the company reported a net income of $755,500 despite an operating loss of $153,630, which suggests that non-operating income or gains may have contributed to the bottom line. The return on equity (ROE) of 1.07% and return on assets (ROA) of 1.06% are below the industry median for investment holding companies, indicating that the company is not generating strong returns relative to its equity and asset base.
The company's revenue is not disclosed in the provided data, and no specific segments or geographic regions are identified. However, the absence of detailed segment reporting is common for investment holding companies, which typically consolidate their operations under a single reporting line. The company's exposure to geographic and segment-specific risks is therefore not quantifiable from the available data.
Looking ahead, the company's growth trajectory is not clearly defined in the provided data. The absence of forward-looking guidance and the lack of historical revenue data make it difficult to assess the company's growth potential. However, the company's strong liquidity position and low debt-to-equity ratio of 0 suggest that it is well-positioned to pursue new investment opportunities or weather economic downturns.
The risk assessment indicates that the company faces low liquidity and dilution risks, with no immediate filing-based flags detected. The company's low debt load and strong equity position reduce the likelihood of financial distress. However, the company's reliance on investment income exposes it to market volatility and the performance of its underlying assets. No dilution risks are currently flagged, and the company's share count has not changed between basic and diluted shares, indicating no imminent pressure from share issuance.
No recent events, such as filings or transcripts, are provided in the data to indicate any material changes in the company's operations or strategy. The company's financial performance and risk profile appear to be stable, with no immediate red flags or significant developments reported in the available data.
- Aimei Health Technology Co Ltd is an investment holding company with a strong liquidity position and no long-term debt.
- The company's ROE and ROA are below the industry median, indicating suboptimal returns on equity and assets.
- The company's capital structure is conservative, with a current ratio of 6.13 and a debt-to-equity ratio of 0.
- The company's growth trajectory is unclear due to the lack of historical revenue data and forward-looking guidance.
- The company faces low liquidity and dilution risks, with no immediate filing-based flags detected.
- The company's exposure to geographic and segment-specific risks is not quantifiable from the available data.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Aimei Health Technology Co Ltd Market data — financials · 2026-05-27
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,02 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
Insider activity
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 15.9%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -174.9%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 169.5%Derived (calculated)
- Return on equity (FY 2025-12-31): -26.1%Derived (calculated)
- Current ratio (FY 2025-12-31): 0.00xDerived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): 21.5%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): -83.6%Derived (calculated)
- Return on assets (FY 2025-12-31): 8.8%Derived (calculated)
- Debt-to-equity (FY 2025-12-31): -1.00xDerived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): -58.5%Derived (calculated)
- Operating cash flow (annual): USD -565.1KSEC XBRL filing
- Total assets (annual): USD 12.1MSEC XBRL filing
- Shares outstanding (annual): 2.13MSEC XBRL filing
- Shareholders' equity (annual): USD -4.06MSEC XBRL filing
- Total liabilities (annual): USD 4.06MSEC XBRL filing
- Current assets (annual): USD 2.93KSEC XBRL filing
- Current liabilities (annual): USD 3.37MSEC XBRL filing
- Operating income (annual): USD -835.76KSEC XBRL filing
- Net income (annual): USD 1.06MSEC XBRL filing
- Shareholders' equity (YoY) (2024-12-31 vs 2023-12-31): -1,000.9%Derived (calculated)
- Return on assets (FY 2024-12-31): 3.5%Derived (calculated)
- Return on equity (FY 2024-12-31): -172.8%Derived (calculated)
- Current ratio (FY 2024-12-31): 0.04xDerived (calculated)
- Debt-to-equity (FY 2024-12-31): -1.02xDerived (calculated)